Corvus Pharmaceuticals logo

Corvus Pharmaceuticals share price today

(CRVS)

Corvus Pharmaceuticals share price is $4.99 & ₹424.03 as on 21 Dec 2024, 2.30 'hrs' IST

$4.99

-0.1

(-1.96%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Corvus Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Corvus Pharmaceuticals from India. Also see the sentimental analysis on Indian investors investing in Corvus Pharmaceuticals. Get details on the Indian mutual funds that are investing in Corvus Pharmaceuticals. Get Analyst recommendations and forecasts along with all the Corvus Pharmaceuticals's financials.

Corvus Pharmaceuticals share price movements

  • Today's Low: $4.76
    Today's High: $5.34

    Day's Volatility :10.84%

  • 52 Weeks Low: $1.30
    52 Weeks High: $10.00

    52 Weeks Volatility :87.0%

Corvus Pharmaceuticals Returns

PeriodCorvus Pharmaceuticals IncIndex (Russel 2000)
3 Months
-8.27%
0.0%
6 Months
172.68%
0.0%
1 Year
193.53%
0.0%
3 Years
88.3%
-19.7%

Corvus Pharmaceuticals Key Statistics

in dollars & INR

Previous Close
$5.09
Open
$5.02
Today's High
$5.34
Today's Low
$4.7613
Market Capitalization
$327.1M
Today's Volume
$2.6M
52 Week High
$10.0
52 Week Low
$1.3
Revenue TTM
$0.0
EBITDA
$-23.3M
Earnings Per Share (EPS)
$-0.99
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-44.91%

How to invest in Corvus Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Corvus Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Corvus Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Corvus Pharmaceuticals or CRVS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Corvus Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Corvus Pharmaceuticals shares which would translate to 0.170 fractional shares of Corvus Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Corvus Pharmaceuticals, in just a few clicks!

Returns in Corvus Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Corvus Pharmaceuticals investment value today

Current value as on today

₹2,95,725

Returns

₹1,95,725

(+195.73%)

Returns from Corvus Pharmaceuticals Stock

₹1,93,529 (+193.53%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Corvus Pharmaceuticals

27%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Corvus Pharmaceuticals on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 27% more investors are searching Corvus Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Corvus Pharmaceuticals

  • Orbimed Advisors, LLC

    10.81%

  • Point72 Asset Management, L.P.

    8.66%

  • Samlyn Capital, LLC

    7.05%

  • Adams Street Partners LLC

    5.10%

  • Vanguard Group Inc

    3.77%

  • Vivo Capital, LLC

    2.33%

Analyst Recommendation on Corvus Pharmaceuticals

Buy

    80%Buy

    20%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Corvus Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Corvus Pharmaceuticals

What analysts predicted

Upside of 215.63%

Current:

$4.99

Target:

$15.75

Insights on Corvus Pharmaceuticals

  • Price Movement

    In the last 7 days, CRVS stock has moved down by -32.4%

Corvus Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Corvus Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Corvus Pharmaceuticals Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Corvus Pharmaceuticals Inc
-44.18%
172.68%
193.53%
88.3%
19.38%
Regeneron Pharmaceuticals, Inc.
-5.73%
-34.03%
-17.11%
13.66%
87.56%
Biontech Se
4.48%
30.56%
7.36%
-56.46%
225.6%
Alnylam Pharmaceuticals, Inc.
-0.55%
10.11%
28.49%
30.99%
109.19%
Vertex Pharmaceuticals Incorporated
-11.79%
-16.36%
-1.97%
78.33%
80.59%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Corvus Pharmaceuticals Inc
NA
NA
0.0
-0.93
-0.45
-0.24
NA
0.79
Regeneron Pharmaceuticals, Inc.
17.51
17.51
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.55
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Corvus Pharmaceuticals Inc
Buy
$327.1M
19.38%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$77.8B
87.56%
17.51
33.61%
Biontech Se
Buy
$26.7B
225.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.8B
109.19%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.1B
80.59%
32.84
-4.51%

About Corvus Pharmaceuticals

corvus pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. with accomplished and talented scientists, and top-tier investors, we are well positioned in an exciting new era of immuno-oncology.
Organization
Corvus Pharmaceuticals
Employees
28
CEO
Dr. Richard A. Miller M.D.
Industry
Health Technology

Management People of Corvus Pharmaceuticals

NameTitle
Dr. Richard A. Miller M.D.
Co-Founder, President, CEO & Chairman of the Board
Dr. Peter A. Thompson FACP, M.D.
Co-Founder & Independent Director
Mr. Leiv Lea
Chief Financial Officer
Dr. William Benton Jones Ph.D.
Senior Vice President of Pharmaceutical Development
Dr. James T. Rosenbaum M.D.
Senior Vice President of Research
Mr. Jeffrey S. Arcara
Chief Business Officer

Important FAQs about investing in Corvus Pharmaceuticals from India :

What is Corvus Pharmaceuticals share price today?

Corvus Pharmaceuticals share price today stands at $4.99, Open: $5.02 ; Previous Close: $5.09 ; High: $5.34 ; Low: $4.76 ; 52 Week High: $10.00 ; 52 Week Low: $1.30. The stock opens at $5.02, after a previous close of $5.09. The stock reached a daily high of $5.34 and a low of $4.76, with a 52-week high of $10.00 and a 52-week low of $1.30.

Can Indians buy Corvus Pharmaceuticals shares?

Yes, Indians can invest in the Corvus Pharmaceuticals (CRVS) from India.

With INDmoney, you can buy Corvus Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Corvus Pharmaceuticals at zero transaction cost.

How can I buy Corvus Pharmaceuticals shares from India?

It is very easy to buy Corvus Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Corvus Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Corvus Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Corvus Pharmaceuticals stocks?

To start investing in Corvus Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Corvus Pharmaceuticals

Today’s highest price of Corvus Pharmaceuticals (CRVS) is $5.34.

Today’s lowest price of Corvus Pharmaceuticals (CRVS) is $4.76.

What is today's market capitalisation of Corvus Pharmaceuticals

Today's market capitalisation of Corvus Pharmaceuticals CRVS is 327.1M

What is the 52 Week High and Low Range of Corvus Pharmaceuticals

  • 52 Week High

    $10.00

  • 52 Week Low

    $1.30

What are the historical returns of Corvus Pharmaceuticals?

  • 1 Month Returns

    -44.18%

  • 3 Months Returns

    172.68%

  • 1 Year Returns

    193.53%

  • 5 Years Returns

    19.38%

Who is the Chief Executive Officer (CEO) of Corvus Pharmaceuticals

Dr. Richard A. Miller M.D. is the current Chief Executive Officer (CEO) of Corvus Pharmaceuticals.